Publikationen, an denen er mitarbeitet Manuel Puig Domingo (9)

2020

  1. A consensus on the diagnosis and treatment of acromegaly comorbidities: An update

    Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E937-E946

  2. Multidisciplinary management of acromegaly: A consensus

    Reviews in Endocrine and Metabolic Disorders, Vol. 21, Núm. 4, pp. 667-678

2017

  1. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2015

  1. Hacia un manejo integral del paciente con diabetes y obesidad. Posicionamiento de la SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC

    Revista Clinica Espanola, Vol. 215, Núm. 9, pp. 505-514

2013

  1. Insuficiencia suprarrenal y su tratamiento sustitutivo. Su realidad en España

    Endocrinologia y Nutricion

2012

  1. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia

    Pain, Vol. 153, Núm. 7, pp. 1382-1389

2010

  1. High prevalence of growth hormone deficiency in severe fibromyalgia syndromes

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 9, pp. 4331-4337

  2. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229

2009

  1. Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: Its efficacy in relation to gender and previous radio therapy

    European Journal of Endocrinology, Vol. 160, Núm. 4, pp. 535-542